Clinical Trial Update: Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial assessing a bevacizumab-containing regimen for metastatic colorectal cancer did not achieve cytotoxic treatment goals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Neoplasm, Colorectal Cancer | Phase 2 | Status: UNKNOWN